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Sir,
Bouchardy et al (2007) reported that the Geneva Cancer Registry
records show a substantial rise in breast cancer incidence in
women under the age of 40 years in the period 2002– 2004, and
called for confirmation of their finding in other population-based
cancer registries. We therefore abstracted data from the cancer
registries of two other French-speaking Swiss Cantons, Vaud and
Neuchaˆtel (Census populations (December 2000) of about 620 300
and 165 700, respectively; Levi et al, 2003a, b).
Table 1 gives annual number of registered breast cancer cases in
women aged 25–39 years and the corresponding age-standardised
rates (on the European standard population) from the two
registries over the period 1995–2005. Over the last 3 years, rates
were around 33/100 000, and there was some rise over the 11-year
calendar period considered (the per cent annual rise was 2.7 in
Vaud, 1.6 in Neuchaˆtel, both not statistically significant), but there
was no substantial nor sudden increase in most recent years.
When older age groups were examined, some upward trends
in breast cancer registrations were observed, particularly in
young and middle-aged women in Vaud, but there was again
no indication of a recent sudden rise. At ages 40–49 years,
rates were 118.5 in 1995 and 184.9 in 2005, the rates were 307 and
338.2 at ages 50–69 years, 339.9 and 338.4 at ages 70– 79 years,
and 358.2 and 366.1 at ages 80 and above. Corresponding
rates for Neuchaˆtel were 126.5 in 1995 and 186.4 in 2005
at age 40 –49 years, 392.8 and 319.7 at age 50–69 years, 251.0
and 423.7 at age 70– 79 years, and 374.4 and 422.5 at ages 80 years
and above.
These data from the Vaud and Neuchaˆtel Cancer Registries
confirm therefore that breast cancer incidence registration has
been rising over the last decade, particularly in young and middle-
aged women. This rise is largely or totally due to increased
detection. In fact, an organised mammography screening pro-
gramme has been in operation in Vaud since 1999 for women aged
50–70 years (Bulliard et al, 2003), and the use of mammography
has increased also in younger women. Breast cancer mortality has
fallen by 30% in French-speaking Swiss women between 1990 and
2002 (Bulliard et al, 2006), further indicating that any appreciable
Table 1 Trends in numbers and age-adjusted (European standard population) incidence rates of breast cancer per 100 000 women aged 25–39 years at
diagnosis in the Cantons of Vaud and Neuchaˆtel, and annual percent change over the period 1995–2005
Year
Cancer registry 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Annual % changea
(95% CI)b
Vaud
Number 16 15 23 27 26 30 23 21 28 22 26 +2.7
Rate/105 22.4 20.8 31.4 36.5 34.7 40.1 30.2 27.4 36.2 27.9 34.1 (0.94–6.4)
Neuchatel
Number 5 6 6 4 6 5 4 5 6 8 6 +1.6
Rate/105 26.5 30.8 31.0 20.7 30.7 25.4 20.0 24.7 29.7 41.4 31.0 (2.3–5.5)
aComputed over the period 1995–2005 using a standard log-linear model. bCI¼ confidence interval.
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real rise in incidence is unlikely. Breast cancer incidence below age
40 has been stable in the USA between 1999 and 2003 (Morbidity
and Mortality Weekly Report, 2007).
The present data do not confirm the existence of a substantial
rise in breast cancer incidence in younger women in recent years.
The upward trends in Geneva may therefore be due to the play of
chance, since they were based only on 50 cases registered in 2003-
2004, or the detection of prevalent cases due to increased use of
mammography in young women in recent years.
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